ESC 365 - State of the Art: HFmrEF - The new middle child

Back

ESC Premium Access

State of the Art: HFmrEF - The new middle child

Session: Heart failure with mid-range and preserved ejection fraction

Topic: Miscellaneous

Speaker: Professor R. De Boer (Rotterdam, NL)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

60 presentations

8 followers

4 more presentations in this session

Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction

Speaker: Doctor G. Savarese (Stockholm, SE)

Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)

Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

Speaker: Doctor M. Gori (Bergamo, IT)

Should we abandon EF to stratify heart failure treatment?

Speaker: Professor S. Solomon (Boston, US)

Access

Slides

Video

Access the full session

Heart failure with mid-range and preserved ejection fraction

Speakers: Professor R. De Boer, Doctor G. Savarese, Doctor A. Aimo, Doctor M. Gori, Professor S. Solomon

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources